139 related articles for article (PubMed ID: 10654894)
1. Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy.
Djavan B; Bursa B; Basharkhah A; Seitz C; Remzi M; Ghawidel K; Hruby S; Marberger M
Urology; 2000 Jan; 55(1):51-7. PubMed ID: 10654894
[TBL] [Abstract][Full Text] [Related]
2. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy.
Laguna MP; Kiemeney LA; Debruyne FM; de la Rosette JJ
J Urol; 2002 Apr; 167(4):1727-30. PubMed ID: 11912397
[TBL] [Abstract][Full Text] [Related]
3. Microwave thermotherapy for benign prostatic hyperplasia.
Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
[TBL] [Abstract][Full Text] [Related]
4. Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy.
Djavan B; Ghawidel K; Basharkhah A; Hruby S; Bursa B; Marberger M
Urology; 1999 Jul; 54(1):73-80. PubMed ID: 10414730
[TBL] [Abstract][Full Text] [Related]
5. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial.
Djavan B; Shariat S; Fakhari M; Ghawidel K; Seitz C; Partin AW; Roehrborn CG; Marberger M
Urology; 1999 Feb; 53(2):251-9. PubMed ID: 9933035
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of prostate-specific antigen after diagnostic procedures and transurethral microwave thermotherapy of benign prostatic hyperplasia.
Daehlin L; Frugård J; Farstad M
Scand J Clin Lab Invest; 1996 May; 56(3):269-73. PubMed ID: 8761531
[TBL] [Abstract][Full Text] [Related]
8. A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia.
Djavan B; Fakhari M; Shariat S; Ghawidel K; Marberger M
J Urol; 1999 Jan; 161(1):144-51. PubMed ID: 10037387
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of temporary prostatic obstruction after high-energy microwave thermothery by placement of prostatic bridge catheter].
Djavan B; Seitz C; Fakhari M; Ghawidel K; Marberger M
Prog Urol; 1999 Apr; 9(2):261-70. PubMed ID: 10370950
[TBL] [Abstract][Full Text] [Related]
10. Three-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study.
Wagrell L; Schelin S; Nordling J; Richthoff J; Magnusson B; Schain M; Larson T; Boyle E; Duelund J; Kroyer K; Ageheim H; Mattiasson A
Urology; 2004 Oct; 64(4):698-702. PubMed ID: 15491704
[TBL] [Abstract][Full Text] [Related]
11. High-energy transurethral microwave thermotherapy in patients with acute urinary retention due to benign prostatic hyperplasia.
Djavan B; Seitz C; Ghawidel K; Basharkhah A; Bursa B; Hruby S; Marberger M
Urology; 1999 Jul; 54(1):18-22. PubMed ID: 10414720
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.
Djavan B; Roehrborn CG; Shariat S; Ghawidel K; Marberger M
J Urol; 1999 Jan; 161(1):139-43. PubMed ID: 10037386
[TBL] [Abstract][Full Text] [Related]
13. Feedback microwave thermotherapy versus TURP for clinical BPH--a randomized controlled multicenter study.
Wagrell L; Schelin S; Nordling J; Richthoff J; Magnusson B; Schain M; Larson T; Boyle E; Duelund J; Kroyer K; Ageheim H; Mattiasson A
Urology; 2002 Aug; 60(2):292-9. PubMed ID: 12137829
[TBL] [Abstract][Full Text] [Related]
14. [Transurethral microwave thermotherapy for benign prostatic hyperplasia].
Murayama K; Hisada K
Hinyokika Kiyo; 2000 Nov; 46(11):799-802. PubMed ID: 11193300
[TBL] [Abstract][Full Text] [Related]
15. Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months.
Djavan B; Seitz C; Roehrborn CG; Remzi M; Fakhari M; Waldert M; Basharkhah A; Planz B; Harik M; Marberger M
Urology; 2001 Jan; 57(1):66-70. PubMed ID: 11164146
[TBL] [Abstract][Full Text] [Related]
16. Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: results in 134 patients after 1 year.
Thalmann GN; Graber SF; Bitton A; Burkhard FC; Gruenig O; Studer UE
J Urol; 1999 Aug; 162(2):387-93. PubMed ID: 10411044
[TBL] [Abstract][Full Text] [Related]
17. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: durability of response.
Baba S; Nakamura K; Tachibana M; Murai M
Urology; 1996 May; 47(5):664-71. PubMed ID: 8650863
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with 1-year follow-up.
Gravas S; Laguna MP; de la Rosette JJ
J Endourol; 2003 Aug; 17(6):425-30. PubMed ID: 12965071
[TBL] [Abstract][Full Text] [Related]
19. Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue?
Khair AA; Pacelli A; Iczkowski KA; Cheng L; Corica FA; Larson TR; Corica A; Bostwick DG
Urology; 1999 Jul; 54(1):67-72. PubMed ID: 10414729
[TBL] [Abstract][Full Text] [Related]
20. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: response durability and variables potentially predicting response.
Terada N; Aoki Y; Ichioka K; Matsuta Y; Okubo K; Yoshimura K; Arai Y
Urology; 2001 Apr; 57(4):701-5; discussion 705-6. PubMed ID: 11306384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
